PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER
Report
- Report Number
- 3005168196-2015-00956
- Event Type
- Malfunction
- Date Received
- September 25, 2015
- Date of Event
- August 27, 2015
- Report Date
- August 27, 2015
- Manufacturer
- PENUMBRA, INC.
- Product Code
- NRY
- UDI-DI
- 00814548012803
- PMA / PMN Number
- K133317
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SN
- Reporter Occupation
- PHYSICIAN
Narratives
RESULT: THE PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER (5MAX ACE) WAS KINKED APPROXIMATELY 3.0 CM FROM THE HUB. CONCLUSION: EVALUATION OF THE RETURNED DEVICE CONFIRMED IT WAS KINKED. THIS TYPE OF DAMAGE TYPICALLY OCCURS DUE TO IMPROPER HANDLING DURING REMOVAL FROM THE PACKAGING. IF THE 5MAX ACE IS REMOVED FROM THE PACKAGING HOOP FORCEFULLY AT AN ANGLE, DAMAGE SUCH AS THIS MAY OCCUR. THESE DEVICES ARE 100% VISUALLY INSPECTED DURING IN-PROCESS INSPECTION. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.
CORRECTION TO SECTIONS: (B)(6) ,K133317.
THE DEVICE HAS BEEN RETURNED AND THE INVESTIGATION RESULTS ARE PENDING. A FOLLOW UP MDR WILL BE SUBMITTED UPON COMPLETION OF THE DEVICE INVESTIGATION.
THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN THE INTERNAL CAROTID ARTERY USING THE PENUMBRA SYSTEM 5MAX ACE 132 REPERFUSION CATHETER (5MAX ACE 132). DURING PREPARATION, AFTER REMOVING THE 5MAX ACE 132 FROM ITS PACKAGING AND FLUSHING IT WITH SALINE, THE PHYSICIAN NOTICED THAT IT WAS KINKED AND THE PROXIMAL END OF THE CATHETER APPEARED TO BE DISLODGED FROM THE CATHETER BRAID. THE 5MAX ACE 132 WAS REMOVED AND THE PROCEDURE CONTINUED USING A NEW 5MAX ACE 132. THERE WAS NO REPORT OF AN ADVERSE EFFECT ON THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 634315 | PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER | NRY | NRY | PENUMBRA, INC. | F41040 | 00814548012803 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR |